Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Alprazolam in Photosensitive Epilepsy
NCT02351115Phase 2Completed
- Sponsor
- NovaPneuma
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of alprazolam in epilepsy (5 arms), sponsored by NovaPneuma. Primary endpoint: Standardized Photosensitivity Range. Started Jan 2015; status: completed.
02
Drugs
alprazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02351115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351115.